Dr Stephen Bright is a clinically-trained psychologist who has worked in the AOD field for the past 20 years specializing in psychometrics, older adults, new and emerging drugs, drug checking and novel drug-assisted psychotherapeutic interventions

Myfanwy Graham is an NHMRC Postgraduate and Monash Research Excellence Scholar. She is a Fellow at the Schaeffer Center for Health Policy & Economics, University of Southern California and a Fulbright Scholar Alumna in public health policy. Myfanwy has served as a consultant for the TGA, WHO, UNODC and NASEM.

Stassi Kypri is a PhD candidate and research assistant at the National Centre for Clinical Research on Emerging Drugs (NCCRED), UNSW, Sydney. His doctoral research involves a mixed-method exploration of ketamine and ketamine analogue use in Australia.

Jai is a drug researcher, harm reduction advocate and drug user interested in a broad range of health research topics. He is particularly interested in research that pertains to harm reduction, drug policy, lived and living experience, and the intersection of these areas and Te Ao Māori

Dr Llew Mills is a postdoctoral researcher with the Discipline of Addiction Medicine, University of Sydney and South-Eastern Sydney Local Health District. His interests are cannabis dependence in a clinical and medicinal context, and in using routinely-collected clinical drug and alcohol data to improve drug and alcohol treatment.

Professor Rebecca McKetin (BSc(Psychol)Hons. PhD) leads a program of research on stimulant use epidemiology and interventions at NDARC, UNSW. Her work involves trialling pharmacotherapies, developing and evaluating the online interventions, and evaluating community-based treatment options. She recently led the Tina Trial, a clinical trial of mirtazapine for methamphetamine use.

Stassi Kypri is a PhD candidate and research assistant at the National Centre for Clinical Research on Emerging Drugs (NCCRED), UNSW, Sydney. His doctoral research involves a mixed-method exploration of ketamine and ketamine analogue use in Australia.

Tony is an ARC DECRA Fellow at School of Psychology, The University of Queensland. His current work applies critical social science theory to: (1) opioid pharmacotherapies; and, (2) experiences of psychedelic consumption and policy.

I am a final year PhD Candidate working on early interventions for substance use in young people with mental ill-health. My background is Persian and I have worked as a clinical psychologist and researcher in the field of substance use for approximately 7 years before moving to Australia.